Vergoeding 2019-2023 voor ATC-subgroep A02BA : H2-antagonisten
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| A02BA01 Cimetidine | 419.610 | 196.230 | 238.120 | 338.170 | 374.330 |
| A02BA02 Ranitidine | 1.847.300 | 1.056.500 | 878.100 | 785.550 | 699.040 |
| A02BA03 Famotidine | 505.590 | 1.773.400 | 3.283.400 | 5.086.600 | 6.732.600 |
| A02BA04 Nizatidine | 37.331 | 5.018 | 20 | . | . |
| Totaal | 2.809.831 | 3.031.148 | 4.399.640 | 6.210.320 | 7.805.970 |